Showing results (101-110 of 374) with videos related to
Sort By:
Pageof 38
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Association between allo-immunoreactive and xeno-immunoreactive subunits of a glycoprotein tumor-associated antigenD M Euhus, R K Gupta, D L MortonSurgery|August 1, 1977
Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patientsD M Rangel, S H Golub, D L MortonJournal of the National Cancer Institute|August 1, 1979
Oncofetal antigen: a tumor-associated fetal antigen immunogenic in manR F Irie, A E Giuliano, D L MortonCancer Research|July 15, 1989
An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapyM H Ravindranath, D L Morton, R F IrieJournal of Clinical Laboratory Analysis|January 1, 1989
Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassayD M Euhus, R K Gupta, D L MortonCancer Research|September 1, 1976
A rapid assay for stimulation of human lymphocytes by tumor-associated antigensJ A Roth, E A Grimm, D L MortonInternational Journal of Cancer|August 1, 1980
Determination of incidence and partial characterization of tumor-associated antigens found in the urine of patients bearing solid tumorsN S Rote, R K Gupta, D L MortonCancer|February 19, 1999
Survival of patients with melanoma of the lower extremity decreases with distance from the trunkE C Hsueh, A Lucci, K Qi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigenD S Hoon, D Yuzuki, M Hayashida, et al.Human Pathology|April 4, 2000
Individualized prognosis for melanoma patientsA J Cochran, D Elashoff, D L Morton, et al.Pageof 38